Causal relationship between mental disorders and abdominal aortic aneurysm: insights from the genetic perspective - Deng, Ming-Gang; Chai, Chen; Wang, Kai; Zhao, Zhi-Hui; Nie, Jia-Qi; Liu, Fang; Liang, Yuehui; Liu, Jiewei (medRxiv, 2024)
Objective This study investigated the genetic link between mental disorders—depression, schizophrenia (SCZ), and bipolar disorder (BIP)—and abdominal aortic aneurysm (AAA).Methods We used global/local genetic correlation analyses and identified shared genomic loci. Bidirectional univariable Mendelian Randomization (UMR) assessed causal directions, with multivariable MR (MVMR) refining the analysis. Mediation analyses examined if known AAA risk factors influenced this relationship.Results Global correlations showed positive links between depression, SCZ, and AAA, but not BIP. Local analyses identified specific genomic regions of correlation. We found 26, 141, and 10 shared loci for AAA with depression, SCZ, and BIP, respectively. UMR indicated significant associations between genetically predicted depression (OR 1.270; 95% CI 1.071-1.504; p = 0.006) and SCZ (OR 1.047; 95% CI 1.010-1.084; p = 0.011) with AAA, but not BIP. These results were confirmed by MVMR analyses. Mediation analyses showed that smoking, hypertension, hyperlipidemia, and coronary atherosclerosis mediated the impact of depression on AAA while smoking mediated SCZ’s impact.Conclusion This study provides evidence that genetically predicted depression and SCZ are linked to an increased risk of AAA, mediated by traditional AAA risk factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The datasets utilized in this study are publicly available; the details can be found in the supplementary method.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets utilized in this study are publicly available; the details can be found in the supplementary method.